Dual orexin receptor antagonists show distinct effects on locomotor performance, ethanol interaction and sleep architecture relative to gamma-aminobutyric acid-A receptor modulators.
about
Pharmacological profiling of zebrafish behavior using chemical and genetic classification of sleep-wake modifiers.Zolpidem reduces hippocampal neuronal activity in freely behaving mice: a large scale calcium imaging study with miniaturized fluorescence microscopeThe Dual Hypocretin Receptor Antagonist Almorexant is Permissive for Activation of Wake-Promoting Systems.Orexin/hypocretin based pharmacotherapies for the treatment of addiction: DORA or SORA?A Computational Method for Unveiling the Target Promiscuity of Pharmacologically Active Compounds.Role of orexin-A in the ventrolateral preoptic area on components of total energy expenditure.Orexin OX2 Receptor Antagonists as Sleep Aids.Opportunities and perspectives for developing orexin receptor antagonists.Structure-activity relationship, biological, and pharmacological characterization of the proline sulfonamide ACT-462206: a potent, brain-penetrant dual orexin 1/orexin 2 receptor antagonist.OREXIN 1 AND 2 RECEPTOR INVOLVEMENT IN CO2 -INDUCED PANIC-ASSOCIATED BEHAVIOR AND AUTONOMIC RESPONSES.The dual orexin receptor antagonist, DORA-22, lowers histamine levels in the lateral hypothalamus and prefrontal cortex without lowering hippocampal acetylcholine.Pharmacological evaluation of orexin receptor antagonists in preclinical animal models of pain.Suvorexant for insomnia in older adults: a perspective review.Psychomotor effects, pharmacokinetics and safety of the orexin receptor antagonist suvorexant administered in combination with alcohol in healthy subjects.Orexin Receptor Antagonists
P2860
Q27308084-085649C0-8F59-4543-A8A4-71325A216F5FQ27331440-729B94B9-0ACC-4379-945F-56C81C033451Q30362407-2A8FEF4B-124E-4F45-869D-F457ED108CA9Q38221344-A1E0D211-2702-4417-B7F3-9BC79DEF3BFBQ38658125-83AA2EDE-7729-4ED1-89DB-85F0B2E44B8AQ38845354-F60B131F-E0CF-4CDE-89D0-E3A3E573DE0CQ39026714-1E8DD59A-4965-4F1C-95A5-02FFAD009B55Q40609526-744FE7F8-2AEA-4189-9B0E-E3B81541151EQ42704416-BE76AAF0-2C3A-406D-A527-0483C890F615Q43065862-AC822D70-79C3-4CA8-842F-5BC48452AA83Q47738084-87873334-9C3A-4647-B88D-50CB7923600FQ48689667-790E899E-50CA-4A09-93E4-C772E20B6A2CQ49720218-3467BFD1-061A-470D-B417-37B4FF639110Q50702299-EA9ABAF0-6DB9-4EAC-AA1A-EF68DF86306AQ59201264-CEB3E7B6-8643-41CE-89D6-6D9F0B7C900D
P2860
Dual orexin receptor antagonists show distinct effects on locomotor performance, ethanol interaction and sleep architecture relative to gamma-aminobutyric acid-A receptor modulators.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 24 December 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Dual orexin receptor antagonis ...... ic acid-A receptor modulators.
@en
Dual orexin receptor antagonis ...... ic acid-A receptor modulators.
@nl
type
label
Dual orexin receptor antagonis ...... ic acid-A receptor modulators.
@en
Dual orexin receptor antagonis ...... ic acid-A receptor modulators.
@nl
prefLabel
Dual orexin receptor antagonis ...... ic acid-A receptor modulators.
@en
Dual orexin receptor antagonis ...... ic acid-A receptor modulators.
@nl
P2093
P2860
P356
P1476
Dual orexin receptor antagonis ...... ric acid-A receptor modulators
@en
P2093
Andres D Ramirez
Anthony L Gotter
Duane R Reiss
Jason M Uslaner
John J Renger
Joseph Brunner
Lihang Yao
Pamela L Tannenbaum
Paul J Coleman
Robert Hodgson
P2860
P356
10.3389/FNINS.2013.00254
P577
2013-12-24T00:00:00Z